Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU1-44P is annotated as a pseudogene of the U1 small nuclear RNA (snRNA) gene family, specifically the 44th pseudogene member. U1 snRNA is a core component of the spliceosomal machinery, recognizing the 5′ splice site during pre-mRNA splicing and involved in a process called telescripting, safeguarding nascent transcripts from premature termination. However, RNU1-44P itself does not encode a functional snRNA and lacks evidence of biological activity, drug interaction, disease association, or recognized therapeutic targeting. U1 snRNA family members (such as RNU1-1, RNU1-2, RNU1-4) are well-studied for their role in splicing and gene regulation, but pseudogene variants (such as RNU1-44P) are generally nonfunctional and do not produce mature or functional RNA molecules. There are no known drugs, mechanisms of action, or biomarker roles for RNU1-44P. Pseudogenes are typically genomic DNA sequences similar to functional genes but rendered non-functional due to mutations or deletions. They may have regulatory roles in rare cases, but there is no evidence for RNU1-44P in the literature or curated databases. RNU1-44P does not fit into canonical molecular families such as receptor, enzyme, channel, or transcription factor. This entry is a pseudogene, not a functional RNA or classical therapeutic target. If you intend to study therapeutically relevant or functional molecules in the U1 snRNA family, refer to canonical snRNA genes (e.g., RNU1-1, RNU1-2, RNU1-4). No actionable disease or drug association reported. No established biological or clinical relevance for patient selection, monitoring, or safety. In summary: RNU1-44P is a pseudogene related to the U1 small nuclear RNA gene family, lacking functional RNA production, protein-coding potential, and relevance as a therapeutic target. No alternative names, drug interactions, disease associations, mechanisms of action, biomarker roles, or safety concerns are described in peer-reviewed databases or expert sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 44, pseudogene (RNU1-44P).